Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
5.03
-0.29 (-5.45%)
At close: May 9, 2025, 4:00 PM
5.03
0.00 (0.00%)
After-hours: May 9, 2025, 7:57 PM EDT
Alumis Employees
As of December 31, 2024, Alumis had 170 total employees, including 168 full-time and 2 part-time employees. The number of employees increased by 61 or 55.96% compared to the previous year.
Employees
170
Change (1Y)
61
Growth (1Y)
55.96%
Revenue / Employee
n/a
Profits / Employee
-$1,730,782
Market Cap
273.67M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170 | 61 | 55.96% |
| Dec 31, 2023 | 109 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALMS News
- 18 days ago - Alumis and ACELYRIN Announce Amended Merger Agreement - GlobeNewsWire
- 23 days ago - ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN - Business Wire
- 25 days ago - Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga
- 4 weeks ago - Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
- 5 weeks ago - Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger - GlobeNewsWire
- 6 weeks ago - Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan - GlobeNewsWire
- 7 weeks ago - Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements - GlobeNewsWire
- 2 months ago - Alumis to Present at Leerink's 2025 Global Healthcare Conference - GlobeNewsWire